Sharma Arun, Toepfer Christopher N, Schmid Manuel, Garfinkel Amanda C, Seidman Christine E
Department of Genetics, Harvard Medical School, Boston, Massachusetts.
Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Curr Protoc Hum Genet. 2018 Jan 24;96:21.12.1-21.12.12. doi: 10.1002/cphg.53.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) represent a powerful cellular platform for illuminating mechanisms of human cardiovascular disease and for pharmacological screening. Recent advances in CRISPR/Cas9-mediated genome editing technology underlie this profound utility. We have generated hiPSC-CMs harboring fluorescently-tagged sarcomeric proteins, which provide a tool to non-invasively study human sarcomere function and dysfunction. In this unit, we illustrate methods for conducting high-efficiency, small molecule-mediated differentiation of hiPSCs into cardiomyocytes, and for performing non-invasive contractile analysis through direct sarcomere tracking of GFP-sarcomere reporter hiPSC-CMs. We believe that this type of analysis can overcome sensitivity problems found in other forms of contractile assays involving hiPSC-CMs by directly measuring contractility at the fundamental contractile unit of the hiPSC-CM, the sarcomere. © 2018 by John Wiley & Sons, Inc.
人诱导多能干细胞衍生的心肌细胞(hiPSC-CMs)是用于阐明人类心血管疾病机制和进行药物筛选的强大细胞平台。CRISPR/Cas9介导的基因组编辑技术的最新进展是这种巨大效用的基础。我们已经生成了带有荧光标记肌节蛋白的hiPSC-CMs,这为非侵入性研究人类肌节功能和功能障碍提供了一种工具。在本单元中,我们阐述了将hiPSC高效、小分子介导分化为心肌细胞的方法,以及通过对GFP-肌节报告基因hiPSC-CMs进行直接肌节追踪来进行非侵入性收缩分析的方法。我们相信,这种类型的分析可以通过在hiPSC-CM的基本收缩单位——肌节处直接测量收缩力,克服在涉及hiPSC-CMs的其他形式收缩测定中发现的灵敏度问题。© 2018约翰威立父子出版公司